BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37615928)

  • 1. Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis.
    Brownson-Smith R; Orange ST; Cresti N; Hunt K; Saxton J; Temesi J
    J Cancer Surviv; 2023 Aug; ():. PubMed ID: 37615928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review.
    Schwab L; Visovsky C
    Front Oncol; 2022; 12():1005083. PubMed ID: 36703798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.
    Bland KA; Kirkham AA; Bovard J; Shenkier T; Zucker D; McKenzie DC; Davis MK; Gelmon KA; Campbell KL
    Clin Breast Cancer; 2019 Dec; 19(6):411-422. PubMed ID: 31601479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise intervention for the management of chemotherapy-induced peripheral neuropathy: a systematic review and network meta-analysis.
    Nakagawa N; Yamamoto S; Hanai A; Oiwa A; Arao H
    Front Neurol; 2024; 15():1346099. PubMed ID: 38352137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
    Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
    Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
    Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
    Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.
    Tanay MAL; Armes J; Moss-Morris R; Rafferty AM; Robert G
    J Cancer Surviv; 2023 Feb; 17(1):254-277. PubMed ID: 33710510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer.
    Cramer H; Lauche R; Klose P; Lange S; Langhorst J; Dobos GJ
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010802. PubMed ID: 28045199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Educational interventions for the management of cancer-related fatigue in adults.
    Bennett S; Pigott A; Beller EM; Haines T; Meredith P; Delaney C
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008144. PubMed ID: 27883365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular revascularisation versus conservative management for intermittent claudication.
    Fakhry F; Fokkenrood HJ; Spronk S; Teijink JA; Rouwet EV; Hunink MGM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010512. PubMed ID: 29518253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer.
    Mo H; Yan X; Zhao F; Teng Y; Sun X; Lv Z; Cao M; Zhao J; Song G; Pan B; Li H; Zhai J; Xu B; Ma F
    JAMA Netw Open; 2022 Nov; 5(11):e2239788. PubMed ID: 36322088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body weight management in overweight and obese breast cancer survivors.
    Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab-containing regimens for metastatic breast cancer.
    Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis.
    Wu S; Bai X; Guo C; Huang Z; Ouyang H; Huang J; Zeng W
    BMC Cancer; 2021 Nov; 21(1):1173. PubMed ID: 34727879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.
    Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC
    Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity for women with breast cancer after adjuvant therapy.
    Lahart IM; Metsios GS; Nevill AM; Carmichael AR
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011292. PubMed ID: 29376559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.